- Home
- Publications
- Publication Search
- Publication Details
Title
BCL-2 protein family: attractive targets for cancer therapy
Authors
Keywords
-
Journal
APOPTOSIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-07
DOI
10.1007/s10495-022-01780-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?
- (2022) Kerstin Brinkmann et al. CELL DEATH AND DIFFERENTIATION
- Roles and Regulation of BCL-xL in Hematological Malignancies
- (2022) Mario Morales-Martínez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Requirement for antiapoptotic MCL-1 during early erythropoiesis
- (2021) Meghan E. Turnis et al. BLOOD
- Targeting MCL-1 in cancer: current status and perspectives
- (2021) Haolan Wang et al. Journal of Hematology & Oncology
- Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy
- (2021) Shuo Ma et al. BLOOD
- BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer
- (2021) Prashanthi Ramesh et al. CELL DEATH AND DIFFERENTIATION
- Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis
- (2020) Hai Vu Nguyen et al. BLOOD
- MCL1 is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice
- (2020) Marc E. Healy et al. GASTROENTEROLOGY
- MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression
- (2020) Yuto Yasuda et al. Cell Death & Disease
- BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
- (2020) Magdalena Klanova et al. Cancers
- Treatment of Relapsed Acute Myeloid Leukemia
- (2020) Felicitas Thol et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically
- (2020) Enkhtsetseg Munkhbaatar et al. Nature Communications
- BCL‐XL exerts a protective role against anemia caused by radiation‐induced kidney damage
- (2020) Kerstin Brinkmann et al. EMBO JOURNAL
- Targeting the Bcl-2 Family in B Cell Lymphoma
- (2019) Clare M. Adams et al. Frontiers in Oncology
- IL-22 Accelerates Thymus Regeneration via Stat3/Mcl-1 and Decreases Chronic Graft-versus-Host Disease in Mice after Allotransplants
- (2019) Bin Pan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
- (2019) Solmaz Shirjang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Context-specific regulation of cell survival by a miRNA-controlled BIM rheostat
- (2019) Verena Labi et al. GENES & DEVELOPMENT
- Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK
- (2018) Francine F.S. Ke et al. CELL
- Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1
- (2018) Rama Cherla et al. INFECTION AND IMMUNITY
- DNA repair processes are critical mediators of p53-dependent tumor suppression
- (2018) Ana Janic et al. NATURE MEDICINE
- MCL-1 is a prognostic indicator and drug target in breast cancer
- (2018) Kirsteen J. Campbell et al. Cell Death & Disease
- Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
- (2018) Shengzhe Zhang et al. Nature Communications
- Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
- (2018) Donia M. Moujalled et al. LEUKEMIA
- AMG 176, a Selective MCL1 Inhibitor, is Effective in Hematological Cancer Models Alone and in Combination with Established Therapies
- (2018) Sean Caenepeel et al. Cancer Discovery
- Exploiting MCL-1 dependency with combination MEK + MCL-1 inhibitors leads to induction of apoptosis and tumor regression in KRAS mutant non-small cell lung cancer
- (2018) Varuna Nangia et al. Cancer Discovery
- Subtle Changes in the Levels of BCL-2 Proteins Cause Severe Craniofacial Abnormalities
- (2018) Stephanie Grabow et al. Cell Reports
- Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
- (2018) Adriana E. Tron et al. Nature Communications
- BCL-W has a fundamental role in B cell survival and lymphomagenesis
- (2017) Clare M. Adams et al. JOURNAL OF CLINICAL INVESTIGATION
- Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
- (2017) John F Seymour et al. LANCET ONCOLOGY
- LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma
- (2017) Kefeng Wang et al. Molecular Cancer
- Pore formation by dimeric Bak and Bax: an unusual pore?
- (2017) Rachel T. Uren et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
- (2017) Delphine Merino et al. Science Translational Medicine
- BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation
- (2016) Fabien Llambi et al. CELL
- Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage
- (2016) Weihua Zhou et al. CLINICAL CANCER RESEARCH
- Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
- (2016) Katelyn L. O'Neill et al. GENES & DEVELOPMENT
- Survival control of malignant lymphocytes by anti-apoptotic MCL-1
- (2016) Y Fernández-Marrero et al. LEUKEMIA
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas
- (2016) Shuhei Osaki et al. Scientific Reports
- Small-molecule inhibitors of the Myc oncoprotein
- (2015) Steven Fletcher et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Mitochondrial apoptosis: killing cancer using the enemy within
- (2015) J Lopez et al. BRITISH JOURNAL OF CANCER
- Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival
- (2015) M Sochalska et al. CELL DEATH AND DIFFERENTIATION
- Cell death induced by endoplasmic reticulum stress
- (2015) Raffaella Iurlaro et al. FEBS Journal
- EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival
- (2015) Nai Yang Fu et al. NATURE CELL BIOLOGY
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
- (2015) J D Leverson et al. Cell Death & Disease
- Regulation of Bim in Health and Disease
- (2015) Ronit Vogt Sionov et al. Oncotarget
- MCL-1 dependency of cisplatin-resistant cancer cells
- (2014) Judith Michels et al. BIOCHEMICAL PHARMACOLOGY
- MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice
- (2014) S. Grabow et al. BLOOD
- Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
- (2014) R. W. Rooswinkel et al. BLOOD
- IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells
- (2014) Aparna R. Shenoy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
- (2014) G. L. Kelly et al. GENES & DEVELOPMENT
- Knockdown of the Antiapoptotic Bcl-2 Family Member A1/Bfl-1 Protects Mice from Anaphylaxis
- (2014) Eleonora Ottina et al. JOURNAL OF IMMUNOLOGY
- Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
- (2014) Zhi-Fu Tao et al. ACS Medicinal Chemistry Letters
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid Tissues
- (2014) Nathiya Muthalagu et al. Cell Reports
- Foxo-mediated Bim transcription is dispensable for the apoptosis of hematopoietic cells that is mediated by this BH3-only protein
- (2013) Marco J Herold et al. EMBO REPORTS
- Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure
- (2013) R. L. Thomas et al. GENES & DEVELOPMENT
- Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
- (2013) X. Wang et al. GENES & DEVELOPMENT
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- Mcl-1 is essential for the survival of plasma cells
- (2013) Victor Peperzak et al. NATURE IMMUNOLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
- (2013) Jie Gao et al. PLoS One
- p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
- (2013) Liz J. Valente et al. Cell Reports
- Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice
- (2012) E. Ottina et al. BLOOD
- NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1
- (2012) A Craxton et al. CELL DEATH AND DIFFERENTIATION
- Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
- (2012) S. P. Glaser et al. GENES & DEVELOPMENT
- Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL
- (2012) Marco A. Hernandez-Luna et al. LEUKEMIA & LYMPHOMA
- Delving deeper: MCL-1's contributions to normal and cancer biology
- (2012) Rhonda M. Perciavalle et al. TRENDS IN CELL BIOLOGY
- Notch-Induced hIL-6 Production Facilitates the Maintenance of Self-Renewal of hCD34+ Cord Blood Cells Through the Activation of Jak-PI3K-STAT3 Pathway
- (2011) Bongkum Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
- (2011) Andreas Strasser et al. EMBO JOURNAL
- PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
- (2011) J. Yuan et al. MOLECULAR CANCER THERAPEUTICS
- Glucocorticoid-Mediated Repression of the Oncogenic microRNA Cluster miR-17∼92 Contributes to the Induction of Bim and Initiation of Apoptosis
- (2011) Jason K. Molitoris et al. MOLECULAR ENDOCRINOLOGY
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells
- (2010) Paul Loar et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Post-transcriptional and post-translational regulation of Bcl2: Figure 1
- (2010) Shaun Willimott et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
- (2010) J. A. Richter-Larrea et al. BLOOD
- Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
- (2010) L. Happo et al. BLOOD
- Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
- (2010) K. J. Campbell et al. BLOOD
- Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists
- (2010) Brian J. Lestini et al. CANCER BIOLOGY & THERAPY
- NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons
- (2010) R Hughes et al. CELL DEATH AND DIFFERENTIATION
- Phosphorylation of Mcl-1 by CDK1–cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest
- (2010) Margaret E Harley et al. EMBO JOURNAL
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Apoptosis-promoted tumorigenesis: -irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death
- (2010) E. M. Michalak et al. GENES & DEVELOPMENT
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- High-risk myeloma is associated with global elevation of miRNAs and overexpression ofEIF2C2/AGO2
- (2010) Yiming Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
- (2010) I. Vikstrom et al. SCIENCE
- p63 and p73, the Ancestors of p53
- (2010) V. Dotsch et al. Cold Spring Harbor Perspectives in Biology
- Phosphorylation of Puma modulates its apoptotic function by regulating protein stability
- (2010) M Fricker et al. Cell Death & Disease
- Cloning and characterization of the 5′UTR of the rat anti-apoptotic Bcl-w gene
- (2009) Martine Uittenbogaard et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing
- (2009) Yao Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia
- (2009) R. W. Stam et al. BLOOD
- Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
- (2009) E M Michalak et al. CELL DEATH AND DIFFERENTIATION
- Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia
- (2009) Edurne San José-Eneriz et al. EUROPEAN JOURNAL OF CANCER
- Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas
- (2009) P. Mu et al. GENES & DEVELOPMENT
- Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver
- (2009) Hayato Hikita et al. HEPATOLOGY
- Control of mitochondrial apoptosis by the Bcl-2 family
- (2009) J. K. Brunelle et al. JOURNAL OF CELL SCIENCE
- MEK/ERK-Mediated Phosphorylation of Bim Is Required to Ensure Survival of T and B Lymphocytes during Mitogenic Stimulation
- (2009) L. A. O'Reilly et al. JOURNAL OF IMMUNOLOGY
- Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia
- (2009) Lauren Véronèse et al. LEUKEMIA RESEARCH
- siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells
- (2009) Dae Kim et al. Molecular Cancer
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- Noxa: at the tip of the balance between life and death
- (2009) C Ploner et al. ONCOGENE
- Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation
- (2009) L A Pradelli et al. ONCOGENE
- miR-122 targets an anti-apoptotic gene, Bcl-w , in human hepatocellular carcinoma cell lines
- (2008) Cliff Ji-Fan Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bcl-2-family proteins and hematologic malignancies: history and future prospects
- (2008) J. C. Reed BLOOD
- Distinct Thresholds Govern Myc's Biological Output In Vivo
- (2008) Daniel J. Murphy et al. CANCER CELL
- Emerging Role of miR-106b-25/miR-17-92 Clusters in the Control of Transforming Growth Factor Signaling
- (2008) F. Petrocca et al. CANCER RESEARCH
- In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute
- (2008) E M Michalak et al. CELL DEATH AND DIFFERENTIATION
- Mcl-1 is a potential therapeutic target in multiple types of cancer
- (2008) C. Akgul CELLULAR AND MOLECULAR LIFE SCIENCES
- Prognostic Impact of Bim, Puma, and Noxa Expression in Human Colon Carcinomas
- (2008) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- The Bcl-w promoter is activated by β-catenin/TCF4 in human colorectal carcinoma cells
- (2008) Abigail Lapham et al. GENE
- Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
- (2008) Yuxing Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
- (2008) Mark S. Cragg et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates γ irradiation–induced thymic lymphoma development
- (2008) Verena Labi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis
- (2008) S. P. Garrison et al. MOLECULAR AND CELLULAR BIOLOGY
- Lapatinib Resistance in HCT116 Cells Is Mediated by Elevated MCL-1 Expression and Decreased BAK Activation and Not by ERBB Receptor Kinase Mutation
- (2008) A. P. Martin et al. MOLECULAR PHARMACOLOGY
- Bcl-2 family proteins and cancer
- (2008) K W Yip et al. ONCOGENE
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now